Cancer Chemotherapy Regimen for Ovarian Cancer
CHAD ovarian(114) _________________________________________________________________ cytoxan......... 600 mg/sqm IV day 1. hexamethylmelami 150 mg/sqm/day orally from day 8 to day 22. adriamycin...... 25 mg/sqm IV day 1. cisplatin....... 50 mg/sqm IV day 1. FREQUENCY....... Repeat cycle every 28 days. reference... Vogl SE. Pagano M. Kaplan BH. Greenwald E. Arseneau J. Bennett B. Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens. Cancer. 51(11):2024-30, 1983 Jun 1. abstract... Thirty-eight women with advanced ovarian cancer were given monthly cycles of intravenous cyclophosphamide, Adriamycin (doxorubicin) and cis-platin, and oral hexamethylmelamine. Of 26 with tumor which would be evaluated for response, 42% had complete remission and 50% partial remission. Median time to disease progression from entry for all 38 patients was 13 months, and median survival 23.5 months. The bulk of tumor at the time chemotherapy was begun was the only significant prognostic factor for time to disease progression and survival. Of the seven women surviving free of disease a median of three years later, five had no mass greater than 2 centimeters in diameter at entry. Toxicity was predominantly myelosuppression and vomiting, with mild peripheral neuropathy in 27% and no significant renal or cardiac toxicity. The response rate of 92% is much higher than that previously reported with melphalan, and the survival considerably longer. The toxicity is acceptable, given the substantial improvement in results.
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community
Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.